Search Results 751-760 of 18386 for Lactation
Lactating females must agree to discontinue nursing before momelotinib administration; Able to understand and willing to sign the informed consent form.
Participation eligibility · Pregnant or lactating. · Structural or metabolic diseases/conditions that affect the gastrointestinal system. · Diagnosis of IBS-M or ...
Male or non-pregnant, non-lactating female, age 2 to 18 years, inclusive as of the day of the Screening Visit. Clinical diagnosis of Dravet syndrome, where ...
are currently pregnant or lactating, or are of child-bearing potential or are likely to become pregnant during the medication phase and are unwilling to use ...
Participant is pregnant, lactating or ≤30 days post-partum. 2. Any cognitive or physical limitations that, in the opinion of the investigator, limits the ...
Pregnant or lactating female. Life expectancy less than 3 months. Intolerance to contrast agents that is refractory to medical management. Any other ...
Pregnant or lactating patients, or patients planning to become pregnant during the clinical study 18. A history of primary malignancy other than BTC will be ...
Female subject is pregnant or lactating. Serious medical or psychiatric illness likely to interfere with participation in this clinical study. CMV sero ...
Pregnant or nursing (lactating) women, where pregnancy is defined as the state of a female after conception and until the termination of gestation ...
Women of child bearing potential must have a negative serum or urine pregnancy test at the Screening Visit and be non-lactating. Accessibility to the site ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your gift to celebrate this day advances our doctors’ lifesaving work.